South Africa’s ambitious National Health Insurance (NHI) plan is facing intense scrutiny. The Health Funders Association (HFA) warns that “uncertainty and contradictions” plague the government’s NHI funding plan. They render it...
South Africa has taken a pivotal step towards pharmaceutical independence with the launch of a new South African cholera vaccine trial. The state-backed manufacturer, Biovac, in partnership with the South African Medical Research Council (SAMRC), has initiated...
High blood pressure, often called the “silent killer,” is a significant public health crisis in South Africa. Implementing home-based hypertension care could be a crucial step in managing this issue. The 2023 Global Burden of Disease report ranked hypertension as the...
State-backed vaccine manufacturer Biovac has officially launched a new product development laboratory at its Cape Town facility. This move strengthens its capacity to produce vaccines entirely on African soil, from start to finish. The new Biovac R&D lab in...
The National Treasury’s emergency allocation to South Africa’s health sector is dangerously insufficient. It is at high risk of being diverted to pay off massive provincial debts rather than fund essential services, Parliament heard on Wednesday. Health...
